AMR Stakeholder Profile
Focus area/active in: Therapeutics
Company/Organisation type: SME
BioVersys AG is a privately owned Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in Anti-Microbial Resistance and targeted microbiome modulation. BioVersys addresses the high unmet medical need for new treatments against life threatening resistant bacterial infections. Our most advanced R&D programs are in preclinical development for nosocomial infections, and Tuberculosis in collaboration with GSK. In 2020 BioVersys plans to launch its first Phase I clinical trials.
Get in touch!
Head Business Development
Please fill out the form below to get in touch with us.